Keep Your Family Healthy
Oral Probiotic BLIS K12™ Further Substantiated as GRAS after Receiving ‘Letter of No Objection’ from US FDA
2 years, 7 months ago Posted in: Keep Your Family Healthy, Oral Probiotics
0
Posted By: Oral Probiotic BLIS K12™ Further Substantiated as GRAS after Receiving ‘Letter of No Objection’ from US FDA

There is a lot of research behind the safety of oral-cavity probiotic, BLIS K12™, however now there is even further safety substantiation for the BLIS K12 ingredient. A ‘Letter of No Objection’ has been received from the US Food and Drug Administration (FDA) on BLIS K12, which refers to the letter sent by the FDA confirming that they do not question the basis for the GRAS (Generally Recognized As Safe) self-affirmation notification submitted by Blis Technologies.

Through the GRAS notification program, companies voluntarily submit their self-affirmation dossier, substantiated by extensive research and expert peer review, that a specific ingredient is Generally Recognized As Safe. The ‘Letter of No Objection’ means that FDA has reviewed all of the scientific data on BLIS K12 and has no questions or concerns regarding its safety.

BLIS K12 is an oral cavity probiotic that has been shown in multiple published clinical trials to provide benefits for supporting ear and throat health in both children and adults.*

Learn more about BLIS K12

 

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Comments are closed.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.